Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy

Immunological Investigations

Volumn 37, Issue 5-6, 2008, Pages 631-644

  Adams Waldorf, Kristina M ^a,b,c   Nelson, J Lee ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Autoimmune disease; Microchimerism; Pregnancy; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

DNA;

AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CELL TRANSPORT; FETUS CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MICROCHIMERISM; PREGNANCY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOPTIVE TRANSFER; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; CHIMERISM; DENDRITIC CELLS; FEMALE; FETAL PROTEINS; GONADAL STEROID HORMONES; HUMANS; IMMUNOLOGIC MEMORY; MATERNAL-FETAL EXCHANGE; ORGANOGENESIS; PHAGOCYTOSIS; PREGNANCY; PREGNANCY COMPLICATIONS; TROPHOBLASTS;

EID: 50049108237     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130802205886     Document Type: Review

References (53)

1. Adams, K. M., Nelson, J. L. (2004). Microchimerism: an investigative frontier in autoimmunity and transplantation. Jama 291(9):1127-31.
2. Adams, K. M., Yan, Z., Stevens, A. M., Nelson, J. L. (2007). The changing maternal "self" hypothesis: a mechanism for maternal tolerance of the fetus. Placenta 28(5-6):378-82.
3. Ando, T., Imaizumi, M., Graves, P. N., Unger, P., Davies, T. F. (2002). Intrathyroidal fetal microchimerism in Graves' disease. J Clin Endocrinol Metab 87(7): 3315-20.
4. Anolik, J. H. (2007). B cell biology and dysfunction in SLE. Bull NYU Hosp Jt Dis 65(3):182-6.
5. Bianchi, D. W., Zickwolf, G. K., Weil, G. J., Sylvester, S., DeMaria, M. A. (1996). Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93(2):705-8.
6. Bijlsma, J. W., Huber-Bruning, O., Thijssen, J. H. (1987). Effect of oestrogen treatment on clinical and laboratory manifestations of rheumatoid arthritis. Ann Rheum Dis 46(10):777-9.
7. Bonilla, W. V., Geuking, M. B., Aichele, P., Ludewig, B., Hengartner, H., Zinkernagel, R. M. (2006). Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest 116(1):156-62.
8. Branch, D. W., Porter, T. F. (1999). Autoimmune disease. High-risk pregnancy management options. S. P. James DK, Weiner CP, Gonik B. London; New York, W. B. Saunders: 853-4.
9. Buyon, J. P., Winchester, R. J., Slade, S. G., Arnett, F., Copel, J., Friedman, D., Lockshin, M. D. (1993). Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 36(9):1263-73.
10. Chan, G. W., Mandel, S. J. (2007). Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab 3(6):470-8.
11. Costenbader, K. H., Feskanich, D., Stampfer, M. J., Karlson, E. W. (2007). Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 56(4):1251-62.
12. Davies, T. F. (1999). The thyroid immunology of the postpartum period. Thyroid 9(7):675-84.
13. Gregersen, P. K., Silver, J., Winchester, R. J. (1987). The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30(11):1205-13.
14. Hench, P. S. (1938). The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrarthrosis. Mayo Clin Proc 13:161-7.
15. Huppertz, B., Kaufmann, P., Kingdom, J. (2002). Trophoblast turnover in health and disease. Fetal Maternal Med Rev 13:103-118.
16. Jacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., McDevitt, H. O. (1990). Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87(3):1233-7.
17. Jiang, S. P., Vacchio, M. S. (1998). Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft". J Immunol 160(7):3086-90.
18. Johnson, M. J., Petri, M., Witter, F. R., Repke, J. T. (1995). Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 86(3):396-9.
19. Klintschar, M., Immel, U. D., Kehlen, A., Schwaiger, P., Mustafa, T., Mannweiler, S., Regauer, S., Kleiber, M., Hoang-Vu, C. (2006). Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur J Endocrinol 154(2):237-41.
20. Klintschar, M., Schwaiger, P., Mannweiler, S., Regauer, S., Kleiber, M. (2001). Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 86(6):2494-8.
21. Kuijpens, J. L., Pop, V. J., Vader, H. L., Drexhage, H. A., Wiersinga, W. M. (1998). Prediction of post partum thyroid dysfunction: can it be improved? Eur J Endocrinol 139(1):36-43.
22. Kung, A. W., Lau, K. S., Kohn, L. D. (2001). Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy. J Clin Endocrinol Metab 86(8):3647-53.
23. Lazarus, J. H., Parkes, A. B., Premawardhana, L. D. (2002). Postpartum thyroiditis. Autoimmunity 35(3):169-73.
24. Lo, Y. M., Lau, T. K., Chan, L. Y., Leung, T. N., Chang, A. M. (2000). Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 46(9):1301-9.
25. Lucas, A., Pizarro, E., Granada, M. L., Salinas, I., Foz, M., Sanmarti, A. (2000). Postpartum thyroiditis: epidemiology and clinical evolution in a nonselected population. Thyroid 10(1):71-7.
26. Maloney, S., Smith, A., Furst, D. E., Myerson, D., Rupert, K., Evans, P. C., Nelson, J. L. (1999). Microchimerism of maternal origin persists into adult life. J Clin Invest 104(1):41-7.
27. Morelli, A. E., Thomson, A. W. (2007). Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7(8):610-21.
28. Nelson, J. L. (1996). Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum 39(2):191-4.
29. Nelson, J. L. (2008). Your cells are my cells. Scientific American 298(2):72-79.
30. Nelson, J. L., Furst, D. E., Maloney, S., Gooley, T., Evans, P. C., Smith, A., Bean, M. A., Ober, C., Bianchi, D. W. (1998). Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 351(9102):559-62.
31. Nelson, J. L., Gillespie, K. M., Lambert, N. C., Stevens, A. M., Loubiere, L. S., Rutledge, J. C., Leisenring, W. M., Erickson, T. D., Yan, Z., Mullarkey, M. E., Boespflug, N. D., Bingley, P. J., Gale, E. A. (2007). Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci USA 104(5):1637-42.
32. Nelson, J. L., Hughes, K. A., Smith, A. G., Nisperos, B. B., Branchaud, A. M., Hansen, J. A. (1993). Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 329(7):466-71.
33. Nelson, J. L., Koepsell, T. D., Dugowson, C. E., Voigt, L. F., Daling, J. R., Hansen, J. A. (1993). Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum 36(1):7-14.
34. Nelson, J. L., Ostensen, M. (1997). Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 23(1):195-212.
35. Ostensen, M. (2000). Glucocorticosteroids in pregnant patients with rheumatoid arthritis. Z Rheumatol 59 Suppl 2:II/70-4.
36. Petri, M., Allbritton, J. (1993). Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol 20(4):650-6.
37. Petri, M., Howard, D., Repke, J. (1991). Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 34(12):1538-45.
38. Petri, M., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Sammaritano, L. R., Lockshin, M., Merrill, J. T., Belmont, H. M., Askanase, A. D., McCune, W. J., Hearth-Holmes, M., Dooley, M. A., Von Feldt, J., Friedman, A., Tan, M., Davis, J., Cronin, M., Diamond, B., Mackay, M., Sigler, L., Fillius, M., Rupel, A., Licciardi, F., Buyon, J. P. (2005). Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353(24):2550-8.
39. Ranella, A., Vassiliadis, S., Mastora, C., Valentina, M., Dionyssopoulou, E., Athanassakis, I. (2005). Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells. Hum Immunol 66(1):43-55.
40. Rashid, M., Rashid, M. H. (2007). Obstetric management of thyroid disease. Obstet Gynecol Surv 62(10):680-8; quiz 691.
41. Ruiz-Irastorza, G., Lima, F., Alves, J., Khamashta, M. A., Simpson, J., Hughes, G. R., Buchanan, N. M. (1996). Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 35(2):133-8.
42. Sanchez-Guerrero, J., Karlson, E. W., Liang, M. H., Hunter, D. J., Speizer, F. E., Colditz, G. A. (1997). Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 40(5):804-8.
43. Sanchez-Guerrero, J., Liang, M. H., Karlson, E. W., Hunter, D. J., Colditz, G. A. (1995). Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 122(6):430-3.
44. Scaletti, C., Vultaggio, A., Bonifacio, S., Emmi, L., Torricelli, F., Maggi, E., Romagnani, S., Piccinni, M. P. (2002). Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 46(2):445-50.
45. Steinborn, A., Rebmann, V., Scharf, A., Sohn, C., Grosse-Wilde, H. (2003). Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy. Am J Obstet Gynecol 188(2):473-9.
46. Stevens AM, H. H., Rutledge, R., Buyon, J., Nelson, J. L. (2003). Maternal microchimerism has myocardial tissue-specific phenotype in neonatal lupus congenital heart block. Lancet in press.
47. Tafuri, A., Alferink, J., Moller, P., Hammerling, G. J., Arnold, B. (1995). T cell awareness of paternal alloantigens during pregnancy. Science 270(5236):630-3.
48. Vyse, T. J., Kotzin, B. L. (1998). Genetic susceptibility to systemic lupus erythematosus. Annu Rev Immunol 16:261-92.
49. Walsh, J. P., Bremner, A. P., Bulsara, M. K., O'Leary, P., Leedman, P. J., Feddema, P., Michelangeli, V. (2005). Parity and the risk of autoimmune thyroid disease: a community-based study. J Clin Endocrinol Metab 90(9):5309-12.
50. Weetman, A. P., McGregor, A. M. (1994). Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15(6):788-830.
51. Wong, G. W., Cheng, S. H., Dorman, J. S. (1999). The HLA-DQ associations with Graves' disease in Chinese children. Clin Endocrinol (Oxf) 50(4):493-5.
52. Yan, Z., Lambert, N. C., Ostensen, M., Adams, K. M., Guthrie, K. A., Nelson, J. L. (2006). Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis. Arthritis Rheum 54(7):2069-2073.
53. Zimmerman, D. (1999). Fetal and neonatal hyperthyroidism. Thyroid 9(7):727-33.